Skip to content

Molecular Autopsy Study

Molecular Autopsy for Sudden Cardiovascular Death

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02168088
Enrollment
100
Registered
2014-06-20
Start date
2014-06-30
Completion date
2030-06-30
Last updated
2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Unexplained Death

Keywords

Sudden unexplained death

Brief summary

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.

Detailed description

This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death, initially in San Diego County with plans to expand nationally and internationally as funding allows. Genetic testing of the index subjects and their parents (or other biological family members if parents are not available) will be assessed for potential heritable causes of sudden death. By combining the wide catchment base of the San Diego Medical Examiner's Office, sequencing expertise of SD-based collaborators, computing power of the San Diego Supercomputer Center and in-house and external genomic analytics, the Scripps Translational Science Institute aims to provide a more complete characterization and understanding of the genetic causes of sudden death. Ultimately, findings from this study will be utilized to identify previously unrecognized mechanism of sudden death allowing for the development of preventative screening programs and potentially life-saving interventions.

Interventions

None listed

Sponsors

Scripps Translational Science Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 45 Years
Healthy volunteers
No

Inclusion criteria

* Index case age between birth - 45 years * Clinical presentation of sudden / unexplained death (believed to be cardiac in nature OR secondary to a massive unprovoked pulmonary embolism with no prior diagnosis of prothrombotic disease)

Exclusion criteria

* Premature death secondary to murder, suicide or external causal event * Premature death thought secondary to known chronic comorbid medical condition * Premature death thought secondary to end-organ failure (kidney, liver, lung) other than heart * Previously diagnosed with hypertrophic cardiomyopathy (HCM) * Prior myocardial infarction (regardless of stenting or bypass) * Prior cerebrovascular accident (stroke or TIA) * History of open heart surgery (for any reason) * History of severe, untreated hypertensive heart disease * History of illicit drug use * History of heavy alcohol abuse * History of severe pulmonary disease * History of morbid obesity

Design outcomes

Primary

MeasureTime frameDescription
Heritable causes of sudden death3 yearsThe primary endpoint for this study is the discovery of genomic information that may help identify a potential cause of death in the index case. This information may inform living, biologically related family members of their potential risk and need for further genomic analysis.

Countries

United States

Contacts

Primary ContactSarah Topol, RN
topol.sarah@scrippshealth.org858-784-2155
Backup ContactEmily Spencer, Phd
egspence@scripps.edu858-784-2029

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026